Report Id: SNS/F&B/1304 | May 2022 | Region: Global | 125 Pages
Report Scope & Overview:
Human Milk Oligosaccharides (HMO) Market size was valued at $187.07 million in 2022, and is estimated to reach $912.13 million by 2030, registering a CAGR of 21.9% from 2023 to 2030.
Human milk oligosaccharide (HMO) is a class of primarily intricate, unconjugated glycans found in high focuses in human milk. HMOs are negligibly processed in the gastrointestinal framework and arrive at the colon flawless, where they shape the miniature biota.
As HMOs are valuable for invulnerability, a few new strategies are being created by central members in the Human Milk Oligosaccharides (HMO) market, for example, detaching HMO from cow milk, utilizing expensive procedures (artificially or enzymatic-ally orchestrating), or using organisms to deliver them. Human Milk Oligosaccharides (HMO) market things are exorbitant, as a ton of human milk is consolidated to convey an unobtrusive amount of HMO. Thus, methods for combination and extraction are improving with consistent innovative work exercises.
The worldwide HMO market has been affected by a portion of the macroeconomic and microeconomic elements saw in a few key nations. This would demonstrate sufficiently able to drive the market fundamentally concerning esteem deals during the gauge time frame. With the ascent in number of babies across the globe, the interest and inclination for HMO-based baby recipe alongside the pattern of embracing sound way of life by devouring practical food and refreshments has fundamentally helped the use of HMO in assembling.
The Human Milk Oligosaccharides (HMO) market is supposed to observe huge income age during the estimated time frame, attributable to increment in application scope in utilitarian food and drinks and baby equation, fast mechanical headway in the product offering, ascend in well-being mindfulness, and quick improvement of the dairy business.
Development in well-being mindfulness prompts expanded utilization of dietary enhancements.
HMOs are interesting, stomach reinforcing supplements, experimentally demonstrated to help stomach related well-being and resistance.
Digitization of retail industry
The presentation of advancements like epitome, nanoencapsulation, and bio-embodiment
The shortfall of marking for reciprocal well-being administrations in addition to conflicting publicizing messages and visual lines.
Impact Of Covid-19:
The COVID-19 pandemic fundamentally affected the Human Milk Oligosaccharides (HMO) market. The interest for HMO expanded during the lockdown because of frenzy purchasing for at-home utilization during the underlying period of the pandemic. Subsequently, the deals of HMOs heightened during the pandemic, because of the way that it fills in as an insusceptibility promoter.
Key Market Segmentation:
Functional Food & Beverages
By Distribution Channel:
Hypermarkets and supermarkets
Drug stores or pharmacy
Online sales channel
Expanding well-being mindfulness alongside the rising utilization of baby recipe is probably going to help the development of the HMO market over the conjecture time frame. The utilization of HMOs has contributed altogether to achieving a significant decrease in the worldwide baby death rate throughout the long term. According to the United Nations International Children's Education Fund (UNICEF), the under-five death rate was one for every 11 youngsters in 1990 which dropped to one for every 26 kids in 2018.
Contingent upon dispersion channel, the pharmacy or drug store section drove the Human Milk Oligosaccharides (HMO) market in 2020. This is credited to the way that to draw in and hold clients during the developing contest from mail-request retailers and supercenters, pharmacy administrators have underlined comfort factors like broadened store hours and drive-through areas.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Abbott Laboratories, BASF S.E., Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Elicityl S.A., Glycom A/S, Glycosyn, Inbiose NV, Medolac Laboratories, Neolacta Lifesciences Pvt. Ltd, Nestle Health Science, Royal DSM, and ZuChem.
|Market Size in 2022||US$ 187.07 Million|
|Market Size by 2030||US$ 912.13 Million|
|CAGR||CAGR 21.9% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• by Type (2’ Fl, 3’ Fl, 3’ Sl, 6’ Sl)
• by Application (Infant Formula, Functional Food & Beverages, Food Supplement)
• by Concentration (Acidic, Neutral)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Abbott Laboratories, BASF S.E., Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Elicityl S.A., Glycom A/S, Glycosyn, Inbiose NV, Medolac Laboratories, Neolacta Lifesciences Pvt. Ltd, Nestle Health Science, Royal DSM, and ZuChem.|
|Key Drivers||•Development in well-being mindfulness prompts expanded utilization of dietary enhancements.|
|Restraints||•Digitization of retail industry|
Frequently Asked Questions (FAQ) :
Ans: HMO market is segmented in types, applications, distribution channels, and concentration.
Ans: Competitive companies in the HMO Market are Abbott Laboratories, BASF S.E., Biosynthesis Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Elicityl S.A., Glycom A/S, Glycosyn, Inbiose NV, Medolac Laboratories, Neolacta Lifesciences Pvt. Ltd, Nestle Health Science, Royal DSM, and ZuChem.
Ans: 2'FL market holds the most extreme piece of the pie of the HMO market.
Ans: The base year determined in the HMO market report is 2021.
Ans: The global human milk oligosaccharides (HMO) market size is estimated to reach $613.84 million by 2028, registering a CAGR of 21.9% from 2021 to 2028.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
184.108.40.206 United Kingdom
220.127.116.11 South Korea
18.104.22.168 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. HMO Market Segmentation on the basis of Type
8.1 2’ Fl
8.2 3’ Fl
8.3 3’ Sl
8.4 6’ Sl
9. HMO Market Segmentation on the basis of Application
9.1 Infant Formula
9.2 Functional Food & Beverages
9.3 Food Supplement
10. HMO Market Segmentation on the basis of Concentration
11. HMO Market Segmentation on the basis of distribution channel,
11.2 Hypermarkets and supermarkets
11.3 Drug stores or pharmacy
11.4 Mass merchandiser
11.5 Departmental stores
11.6 Mono-brand stores
11.7 Specialty stores
11.8 Online sales channel
12. Regional Analysis
12.2 North America
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4.2 South Korea
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.3 South Africa
12.6 Latin America
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Abbott Laboratories
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 BASF S.E.
13.3 Biosynth Carbosynth
13.4 Chr. Hansen Holding A/S
13.5 Dextra Laboratories Ltd.
13.6 Dupont Nutrition & Biosciences
13.7 Elicityl S.A.
13.8 Glycom A/S
13.10 Inbiose N
13.11 Medolac Laboratories
13.12 Neolacta Lifesciences Pvt. Ltd
13.13 Nestle Health Science
13.13 Royal DSM
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share analysis
15.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.